hsa-miR-574-3p

ncRNA information

ncRNA name

hsa-miR-574-3p

Specific or universal ncRNAs

Specific ncRNAs

Class

MicroRNA

Biomarker

No

Biomarker application

Upstream regulatory factors

Not available

Downstream target

ZEB1

Cancer information

Cancer name

Gastric Carcinoma

Cancer site

Stomach

Treatment information

Treatment type

Chemotherapy

Drug

Cisplatin

Impact of wild-type ncRNA on chemotherapy resistance

Down

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

MiR-574-3p inhibited the EMT and enhanced cisplatin sensitivity in GC cells by suppressing ZEB1.

Tissue resource

human embryonic kidney cell lines HEK-293T

human gastric cancer cell lines SGC7901

human gastric cancer cell lines AGS

human gastric cancer cell lines BGC823

human gastric cancer cell lines MGC803

human gastric cancer cell lines HGC27

Experiment

qRT-PCR,Dual-luciferase reporter assay


Institute

the Institute of Biochemistry and Cell Biology

Country

China

Continent

Asia